So I understand that
The Haematological Malignancy Patient-Reported Outcome (HM-PRO) is a validated tool, assessing symptom burden and impact of disease on QoL, comprisimg Part-A (physical, social well-being, emotional behaviour, eating/drinking habits) and Part-B (symptoms)
"Against the backdrop of anticipated double-digit health care cost increases, fueled to a large degree by GLP-1s and overall prescription drug costs, companies cannot ignore the reality that GLP-1s have significant implications for health care budgets and overall affordability." GLP-1 drugs such as Ozempic, Wegovy and Mounjaro can cost more than $1,000 per month without insurance, according to the National Academy of Medicine
Weight loss might be faster in the beginning
DASS, Depression Anxiety Stress Scales
Online telehealth providers like mine make it easier and more affordable to get safe, effective GLP-1 treatment from home no waiting rooms, no referrals